Enhanced responses of the basilar artery to activation of endothelin-B receptors in stroke-prone spontaneously hypertensive rats

Hypertension

Volumn 25, Issue 4 I, 1995, Pages 490-494

  Kitazono, Takanari ^b   Heistad, Donald D ^a   Faraci, Frank M ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

acetylcholine; arginine; cerebral arteries; endothelium derived relaxing factor; nitro compounds; rats, inbred SHR

Indexed keywords

ACETYLCHOLINE; ARACHIDONIC ACID; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIUM DERIVED RELAXING FACTOR; GALLAMINE TRIETHIODIDE; GLIBENCLAMIDE; INDOMETACIN; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PENTOBARBITAL; PROSTANOID; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL EXPERIMENT; ARTERY DIAMETER; ARTICLE; BASILAR ARTERY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG SELECTIVITY; HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; TOPICAL DRUG ADMINISTRATION; VASODILATATION;

EID: 0028931277     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.25.4.490     Document Type: Article

References (42)

1. Luscher TF, Oemar BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors: part I. J Hypertens. 1993;11:7-11.
2. Luscher TF, Oemar BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors: part II. J Hypertens. 1993;11:121-126.
3. Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci. 1989;10:374-378.
4. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi Y, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separated genes. Proc Natl Acad Sci U S A. 1989;86:2863-2867.
5. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation: implications for vascular function. Circulation. 1991;84:1457-1468.
6. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 1992;13:103-108.
7. B receptor. Biochem Biophys Res Commun. 1992;184:953-959.
8. B receptor in endothelial cells. J Biol Chem. 1994; 269:21778-21785.
9. B receptors in vivo. J Pharmacol Exp Ther. In press.
10. Luscher TF, Seo B, Buhler FR. Potential role of endothelin in hypertension: controversy on endothelin in hypertension. Hypertension. 1993;21:752-757.
11. Masaki T. Overview: reduced sensitivity of vascular response to endothelin. Circulation. 1993;87(suppl V):V-33-V-35.
12. Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension. 1993;21:747-751.
13. Mayhan WG, Faraci FM, Heistad DD. Impairment of endothelium-dependent responses of cerebral arterioles in chronic hypertension. Am J Physiol. 1987;253:H1435-H1440.
14. Mayhan WG, Faraci FM, Heistad DD. Responses of cerebral arterioles to adenosine 5′-diphosphate, serotonin, and the thromboxane analogue U-46619 during chronic hypertension. Hypertension. 1988;12:556-561.
15. Mayhan WG. Impairment of endothelium-dependent dilatation of basilar artery during chronic hypertension. Am J Physiol. 1990;259: H1455-H1462.
16. Tefsman B, Halpern W. Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension. 1988;11:440-444.
17. Van de Voorde J, Leusen I. Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats. Am J Physiol. 1986;250:H711-H717.
18. Koga T, Takata Y, Kobayashi K, Takishita S, Yamashita Y, Fujishima M. Age and hypertension promote endothelium-dependent contractions to acetylcholine in the aorta of the rat. Hypertension. 1989;14:542-548.
19. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
20. Faraci FM, Heistad DD, Mayhan WG. Role of large arteries in regulation of blood flow to brain stem in cats. J Physiol (Lond). 1987;387:115-123.
21. B receptor. Br J Pharmacol. 1993;109:486-490.
22. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
23. Yang S-T, Mayhan WG, Faraci FM, Heistad DD. Endothelium-dependent responses of cerebral blood vessels during chronic hypertension. Hypertension. 1991;17:612-618.
24. Kitazono T, Heistad DD, Faraci FM. ATP-sensitive potassium channels in the basilar artery during chronic hypertension. Hypertension. 1993;22:677-681.
25. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
26. Feger GI, Schilling L, Ehrenreich H, Wahl M. Endothelin-induced contraction and relaxation of rat isolated basilar artery: effect of BQ-123. J Cereb Blood Flow Metab. 1994;14:845-852.
27. B receptor and nitric oxide in cats. Neurosci Lett. 1994;176:157-160.
28. Fozard JR, Part ML. No major role for atrial natriuretic peptide in the vasodilator response to endothelin-1 in the spontaneously hypertensive rat. Eur J Pharmacol. 1990;180:153-159.
29. Kitazumi K, Shiba T, Nishiki K, Furukawa Y, Takasaki C, Tasaka K. Vasodilator effects of sarafotoxins and endothelin-1 in spontaneously hypertensive rats and rat isolated perfused mesentery. Biochem Pharmacol. 1990;40:1843-1847.
30. Winquist RJ, Bunting PB, Garsky VM, Lumma PK, Schofield TL. Prominent depressor response to endothelin in spontaneously hypertensive rats. Eur J Pharmacol. 1989;163:199-203.
31. Wright CE, Fozard JR. Differences in regional vascular sensitivity to endothelin-1 between spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol. 1990;100:107-113.
32. B receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am J Physiol. 1993;264:C479-C484.
33. Faraci FM, Brian JE. Nitric oxide and the cerebral circulation. Stroke. 1994;25:692-703.
34. Faraci FM, Heistad DD. Role of ATP-sensitive potassium channels in the basilar artery. Am J Physiol. 1993;264:H8-H13.
35. Yanagisawa M. The endothelin system: a new target for therapeutic intervention. Circulation. 1994;89:1320-1323.
36. Faraci FM. Role of nitric oxide in regulation of basilar artery tone in vivo. Am J Physiol. 1990;259:H1216-H1221.
37. Gryglewski RJ, Botting RM, Vane JR. Prostacyclin: from discovery to clinical application. In: Rubanyi GM, ed. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. Mount Kisco, NY: Futura; 1991:3-37.
38. Filep JG, Battistini B, Cote YP, Beaudoin AR, Sirois P. Endothelin-1 induces prostacyclin release from bovine aortic endothelial cells. Biochem Biophys Res Commun. 1991;177:171-176.
39. Taddei S, Vanhoutte PM. Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension. 1993;21:9-15.
40. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. 1988;9:272-274.
41. Cosentino F, Katusic ZS. Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm? Stroke. 1994;25:904-908.
42. Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpozio AC. Nonpeptide endothelin antagonist: cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke. 1994;25:2450-2456.